Comparison tool
Compare peptides
Pick up to three compounds. Useful for deciding whether two peptides in a stack actually do different things, or whether you're paying twice for the same pathway.
Select up to three (1/3)
| Attribute | |
|---|---|
| Category | Longevity |
| Evidence grade | Emerging |
| Also known as | Nicotinamide adenine dinucleotide |
| Mechanism | Serves as an electron carrier in redox reactions and as the required substrate for sirtuins and PARP enzymes, which govern DNA repair and mitochondrial biogenesis. |
| Key benefits | Reported energy and mental-clarity improvements · Supports sirtuin-mediated DNA repair pathways · Used adjunctively in recovery clinics |
| Side effects | Flushing, chest tightness and nausea during rapid infusion · Injection-site pain · Headache |
| Half-life | Very short in circulation |
| Administration | IV infusion, subcutaneous injection or nasal spray |
| Dosing overview | IV 250–750 mg per session; subcutaneous 50–100 mg several times weekly |
| Storage | Refrigerated, light-protected |
| Legal status | Compounded and sold in clinics; not an approved drug for ageing. |
Dosing figures reflect published literature and commonly reported community protocols. They are informational only.